Applied Dna Sciences Inc (NASDAQ:BNBX) Sees Significant Decrease in Short Interest

Applied Dna Sciences Inc (NASDAQ:BNBX) was the target of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 231,818 shares, a decrease of 64.2% from the April 15th total of 647,929 shares. Based on an average daily trading volume, of 3,279,719 shares, the days-to-cover ratio is currently 0.1 days. Currently, 4.4% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Applied Dna Sciences currently has a consensus rating of “Sell”.

Applied Dna Sciences Stock Down 4.2%

Shares of BNBX traded down $0.02 on Thursday, reaching $0.46. The company’s stock had a trading volume of 7,058 shares, compared to its average volume of 634,195. Applied Dna Sciences has a twelve month low of $0.45 and a twelve month high of $12.75. The firm has a market cap of $2.61 million, a PE ratio of 0.00 and a beta of 0.58. The company has a fifty day moving average of $0.63.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.